Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-06-18T02:54:58.149Z Has data issue: false hasContentIssue false
  • English
  • Français

Respuesta farmacoterapéutica de pacientes límite positivos en la DST

Published online by Cambridge University Press:  12 May 2020

V. P. Kontaxakis ,
G. N. Christodoulou ,
M. Markianos  and
C. Stefanis
V. P. Kontaxakis
Affiliation:
Departamento de Psiquiatría, Universidad de Atenas, Hospital Eginition, Atenas, Grecia
G. N. Christodoulou
Affiliation:
Departamento de Psiquiatría, Universidad de Atenas, Hospital Eginition, Atenas, Grecia
M. Markianos
Affiliation:
Departamento de Psiquiatría, Universidad de Atenas, Hospital Eginition, Atenas, Grecia
C. Stefanis
Affiliation:
Departamento de Psiquiatría, Universidad de Atenas, Hospital Eginition, Atenas, Grecia
Get access

Resumen

Se presentan los casos de dos pacientes límite, positivos en la prueba de supresión con dexametasona (DST) y refractarios a numerosas intervenciones terapéuticas, tratados con éxito con dosis altas de amitriptilina (225 y 200 mg/día, respectivamente). Durante la intervención terapéutica, se valoró el estado psicopatológico de los pacientes utilizando la Escala de Evaluación de Hamilton para la Depresión y una escala construida basada en los elementos 11, 12 y 13 (disforia, ira, sensación de vacío, aburrimiento y anhedonia) de la entrevista diagnóstica para pacientes límite.

Keywords

trastorno límite de la personalidadDSTfármacos antidepresivos
Type
Comunicación breve
Information
European Psychiatry (Ed. Española) , Volume 2 , Issue 5 , October 1995 , pp. 324 - 326
Copyright
Copyright © European Psychiatric Association 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 3rd ed. Washington DC, 1980.Google Scholar
Brown, WAJohnston, RMayfield, DThe 24-hour dexamethasone suppression test in a clinical setting. Relationship to diagnosis, symptoms, and response to treatment. Am J Psychiatry 1979; 136: 543–7.CrossRefGoogle Scholar
Brown, WAShuey, IResponse to Dexamethasone and subtype of depression. Arch Gen Psychiatry 1980; 37: 747–51.CrossRefGoogle ScholarPubMed
Carrol, BJThe dexamethasone suppression test for melancholia. Br J Psychiatry 1982; 140: 292-304.Google Scholar
Coppen, AMilly, PHarwood, JWood, KDoes the dexamethasone suppression test predict antidepressant treatment success? Br J Psychiatry 1985; 146: 294–6.CrossRefGoogle ScholarPubMed
Cowdry, RWGardner, DLPharmacotherapy of borderline personality disorder. Arch Gen Psychiatry 1988; 45: 111–9.CrossRefGoogle ScholarPubMed
Gardner, DLGowdry, RWBorderline personality disorder: A research challenge. Biol Psychiatry 1989; 45: 111–9.Google Scholar
Gunderson, JGPharmacotherapy for patients with Borderline personality disorder. Arch Gen Psychiatry 1986; 43: 698-700.CrossRefGoogle ScholarPubMed
Gunderson, JGKobb, JEAustin, VThe diagnostic interview for borderline patients. Am J Psychiatry 1981; 138: 896-903.Google ScholarPubMed
Gunderson, JGElliot, GRThe interface between borderline personality disorder and affective disorder. Am J Psychiatry 1986; 142: 247–87.Google Scholar
Hamilton, MARating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.CrossRefGoogle ScholarPubMed
Hartocolis, PTime and affects in Borderline disorders. Int J Psychoanal 1978; 59: 157–63.Google Scholar
Kontaxakis, VMarkianos, MValsamatzis, GMarkidis, MKanellos, PStefanis, CMultiple neuroendocrinological responses in borderline personality disorder patients. Acta Psychiatr Scand 1987; 76: 593–7.CrossRefGoogle ScholarPubMed
Nelson, JCCarolyn, MMJatlow, PIValue of the DST for predicting response of patients with major depression to hospitalization and desipramine. Am J Psychiatry 1990; 147: 1488–92.Google ScholarPubMed
Pope, HGJonas, JMHundson, JJCohen, BMGunderson, JThe validity of the DSMIII borderline personality disorder: A phenomenological, family history, treatment response, and long-term follow-up study. Arch Gen Psychiatry 1983; 40: 23-30.CrossRefGoogle Scholar
Snyder, SPitt, WMCharacterizing anger in the DSMIII borderline personality disorder. Acta Psychiatr Scand 1985; 72: 464–9.CrossRefGoogle Scholar
Snyder, SSajadi, CPitt, WMGoodpaster, WAIdentifying the depressive border of the borderline personality disorder. Am J Psychiatry 1982; 139: 814–7.Google ScholarPubMed
Teicher, MHGlod, CAPharmacotherapy of patients with borderline personality disorder. Hosp and Community Psychiatry 1989; 40: 887–9.Google ScholarPubMed